EcoDrugPlus

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSSLUG00000019153
Gene Symbol: HSP90AB1
1 Cross references
339 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSSLUG00000001246
Gene Symbol: LOC116066028
3 Cross references
330 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSSLUG00000011061
Gene Symbol: HMGB1B
1 Cross references
509 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSSLUG00000009637
Gene Symbol: LOC116036923
2 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSSLUG00000010251
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSSLUG00000005947
Gene Symbol: HRH2
1 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSSLUG00000001391
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSSLUG00000001982
Gene Symbol: HDAC1
3 Cross references
255 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSSLUG00000012634
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSSLUG00000020749
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSSLUG00000011799
Gene Symbol: HDAC3
3 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSSLUG00000009515
Gene Symbol: HDAC4
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).